Case Study

Emilie is a typical Asthma patient. Many young women suffer from Asthma. Around 50% of Asthma patients are not receiving correct care.

​

Because Emilie’s Asthma was not appropriately treated, she missed activities and lost school days due to illness. Emilie was diagnosed with Asthma as a child and was treated with corticosteroids. When she stopped feeling the symptoms associated with Asthma for a longer period of time, she discontinued the medication.

​

However, as a teenager she experienced other symptoms – including fatigue and frequent airway infections. Only when her airway symptoms got very severe, did she consult a doctor, who among other things used an exhaled nitic oxide measurement to ascertain that there was a serious inflammation in her lungs. She had a severe case of untreated Asthma, which was the root cause to many of the problems she had experienced.

​

Asthma symptoms are often diffuse. It can be quite difficult for patients to feel that they have an Asthma that requires treatment. This often leads to non-compliance with medication. With the new SpiroFriend Asthma Device, Asthma patients can self-monitor on a daily basis using analysis that is currently only available for diagnostics, and oftentimes only available in specialized clinics. The objective indicator supplements the patient’s own impressions on a daily basis and leads to a better understanding of the patient’s needs as they evolve.

​

The access to objective indicators of inflammation can also help and reassure parents as they manage their children’s Asthma.  Much like measuring temperature it is not a diagnostic, but the Asthma device measures objective indicators that can help guide the decisions of a parent.

Furthermore, self-measurement can also help early identification of cases, where the prescribed medication does not have an effect, and where the diagnostics or medication need revision.